Location History:
- Minnetonka, MN (US) (1994 - 1996)
- Chapel Hill, NC (US) (2004 - 2008)
Company Filing History:
2 out of 53 
1 out of 19 
2 out of 832,843 Years Active: 1994-2008
Title: The Innovations of Robert A. Olmsted
Introduction
Robert A. Olmsted is a notable inventor based in Minnetonka, MN (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 5 patents to his name, Olmsted's work has had a considerable impact on medical science.
Latest Patents
Among his latest patents is the invention of alpha virus-based cytomegalovirus vaccines. This invention provides methods and compositions that include a population of alphavirus replicon particles. These particles comprise alphavirus replicon RNAs, with one replicon RNA encoding cytomegalovirus pp65 and IE1 protein, while the other encodes cytomegalovirus gB protein. Another significant patent involves alphavirus vectors and virosomes with modified HIV genes for use in vaccines. This invention includes methods and compositions comprising a population of alphavirus replicon particles that contain isolated nucleic acids encoding various gene products of the human immunodeficiency virus, modified to inhibit certain viral activities.
Career Highlights
Throughout his career, Robert A. Olmsted has worked with Secure Computing Corporation, where he contributed to advancements in cybersecurity and technology. His innovative spirit and dedication to research have led to breakthroughs in vaccine development.
Collaborations
Olmsted has collaborated with notable individuals in his field, including William E. Boebert and Thomas R. Markham. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Robert A. Olmsted's contributions to biotechnology and vaccine development highlight his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving public health.